About
About Indoco Remedies Limited
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, extractables and leachables studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
Visit company website
5 years, 4 months ago
Indoco Remedies Limited is currently in a long term uptrend where the price is trading 46.0% above its 200 day moving average.
From a valuation standpoint, the stock is 54.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Indoco Remedies Limited's total revenue rose by 15.3% to $3B since the same quarter in the previous year.
Its net income has increased by 178.7% to $254M since the same quarter in the previous year.
Finally, its free cash flow fell by 54.8% to $245M since the same quarter in the previous year.
Based on the above factors, Indoco Remedies Limited gets an overall score of 4/5.